IVDs are essential for disease detection, personalized treatment, and public health, driving growth in the global diagnostics ...

As data volumes accelerate, AI is becoming deeply embedded in safety operations and local qualified persons for PV are ...

Commentaries are opinion pieces contributed by readers and newsmakers. VTDigger strives to publish a variety of views from a broad range of Vermonters. Commentaries give voice to community members and ...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- IQVIA (NYSE: IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and ...

IQVIA (NYSE: IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced a strategic ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A fast-growing company is close ...

How little noise did IQVIA make about its recent highly significant acquisition of Throtle? The change in ownership is noted in a single sentence on the “About” page on Throtle’s website: “Throtle Inc ...

Pharmacovigilance is increasingly adopted across pharmaceutical companies, regulatory bodies, clinical research organizations, and healthcare providers due to its critical role in monitoring, ...

IQVIA Holdings Inc. (NYSE:IQV) Q3 2025 Earnings Call Transcript October 28, 2025 IQVIA Holdings Inc. beats earnings expectations. Reported EPS is $3, expectations were $2.98. Operator: Ladies and ...

View source version on businesswire.com: https://www.businesswire.com/news/home/20251028775617/en/ The articles, information, and content displayed on this webpage ...

IQVIA is unveiling a new suite of tools designed to manage all the financial components of clinical trials. The company is using an artificial-intelligence-enabled platform to help remove ...